Subsense Expands Financing to $27 Million to Accelerate R&D for Non-Surgical Brain-Computer Interfaces

Subsense 融资扩大至 2700 万美元，以加速非侵入式脑机接口的研发。

After achieving early breakthroughs in materials development, in vitro nanoparticle stimulation and signal reading, Subsense secures additional $10 million to accelerate product development and clinical translation

在材料开发、体外纳米粒子刺激和信号读取方面取得早期突破后，Subsense 获得额外 1000 万美元资金以加速产品开发和临床转化。

PALO ALTO, Calif., December 11, 2025-- Subsense, Inc., a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding to $27 million. The investment from Golden Falcon Capital will accelerate research and development in nanoparticle sensing, in vivo biosafety programs, next-generation nanoparticle design, and hardware miniaturization..

加利福尼亚州帕洛阿尔托，2025年12月11日——非侵入性纳米颗粒脑机接口（BCI）开发商Subsense, Inc.在取得早期突破性进展后，新增了1000万美元资本，总融资额达到2700万美元。来自金隼资本的投资将加速纳米颗粒传感、体内生物安全计划、下一代纳米颗粒设计以及硬件小型化的研究与开发。

Subsense is building a bidirectional BCI platform designed to record and modulate brain activity without surgical implants. Its technology pairs engineered nanoparticles, administered nasally to cross the blood-brain barrier, with proprietary hardware and signal-processing software. Together, these systems aim to achieve higher temporal and spatial resolution of reading and stimulation than current solutions, while also avoiding the risks and costs associated with surgically invasive electrodes or “brain chips.”.

Subsense正在开发一种双向脑机接口（BCI）平台，旨在无需手术植入的情况下记录和调节大脑活动。其技术将通过鼻腔给药以穿越血脑屏障的工程纳米颗粒，与专有硬件和信号处理软件相结合。这些系统共同旨在实现比当前解决方案更高的读取和刺激的时间及空间分辨率，同时避免了手术侵入性电极或“脑芯片”相关的风险和成本。

“We are developing a new kind of neural interface, which integrates seamlessly with the human body,' said Tetiana Aleksandrova, Subsense Co-founder and CEO. “This bio-integrated approach is fundamentally enhancing safety and expanding accessibility.”

“我们正在开发一种新型的神经接口，它可以与人体无缝集成，”Tetiana Aleksandrova，Subsense联合创始人兼首席执行官表示。“这种生物集成方法正在从根本上提高安全性并扩大可及性。”

Subsense recently opened a laboratory and engineering facility in Palo Alto, California, in addition to its research collaborations across North America and Europe. Its growing technology portfolio spans nanoparticle chemistry, magnetic signal transduction, and proprietary neural decoding algorithms aimed at safe, reversible, and high-fidelity brain data capture..

Subsense最近在加利福尼亚州帕洛阿尔托开设了一个实验室和工程设施，此外还在北美和欧洲开展了研究合作。其不断扩展的技术组合涵盖纳米粒子化学、磁信号转导以及专有的神经解码算法，旨在实现安全、可逆且高保真的大脑数据捕获。

Non-surgical BCIs are an emerging priority across neurotechnology and human-machine interface research. While invasive systems have shown clinical potential, accessibility and biosafety remain major barriers to scale. Subsense’s nanoparticle model represents a distinct pathway that may allow population-scale neural data capture without surgery, anesthesia, or implanted electrodes.

非侵入式脑机接口（BCI）正成为神经技术和人机界面研究中的新兴重点。尽管侵入式系统已显示出临床潜力，但可及性和生物安全性仍是规模化的主要障碍。Subsense的纳米粒子模型代表了一种独特的途径，可能在无需手术、麻醉或植入电极的情况下实现大规模神经数据采集。

Subsense’s platform is designed to allow updates, improvements, and reconfigurations over time, unlike fixed hardware, ensuring continued compatibility with future formulations and signal models..

Subsense的平台设计允许随着时间的推移进行更新、改进和重新配置，不同于固定硬件，确保与未来的配方和信号模型保持持续兼容性。

The additional financing showcases growing investor interest in non-surgical and hybrid BCI approaches, as neurotech firms race to deliver commercial-grade interfaces that have the potential to reach the largest market. By 2030, the field is expected to surpass $3 billion globally, driven by advances in materials science, machine learning, and the convergence of health and computing interfaces..

这笔额外的融资展示了投资者对非侵入式和混合脑机接口方法日益增长的兴趣，因为神经科技公司正在竞相推出有潜力覆盖最大市场的商用级接口。到2030年，随着材料科学、机器学习以及健康与计算接口的融合推动，该领域预计将在全球范围内超过30亿美元。

ABOUT SUBSENSE

关于SUBSENSE

Subsense, Inc. is a neurotechnology company developing the first non-surgical, nanoparticle-based bidirectional brain-computer interface. Subsense is partnered with leading global neurological research institutions. The company is venture-backed with its global headquarters in Palo Alto, California and was co-founded by neurotech entrepreneur Tetiana Aleksandrova..

Subsense公司是一家神经技术公司，正在开发首个非手术、基于纳米粒子的双向脑机接口。Subsense与全球领先的神经学研究机构合作。该公司总部位于加利福尼亚州帕洛阿尔托，由神经科技企业家特蒂亚娜·亚历山德罗娃联合创立，并得到了风险投资的支持。

Contact:

联系人：

Media Contact

媒体联系人

Patrick Schmidt

帕特里克·施密特

subsense@consortpartners.com

子意识@联盟伙伴.com